Internal validation cohort of breast cancers for development of ClinicoMolecular Triad Classification

In our early study (PMID: 21939527), we have created a ClinicoMolecular Triad Classification (CMTC) to improve prediction and prognostication of breast cancer by using a training cohort contained 161 breast cancer patients (2003 to 2008). Here, a supplemental internal validation cohort contained 340 breast cancer patients was collected (2008 to 2010) for development of the CMTC.

340

Wang DY, Done SJ, Mc Cready DR, Leong WL